Am J Transplant, Volume 21, Suppl 3 Archives - Page 109 of 139 - ATC Abstracts

2021 American Transplant Congress
A Machine Learning-Based Predictive Model for Outcome of Covid-19 in Kidney Transplant Recipients
I. Revuelta¹, F. Santos-Arteaga², D. Di Caprio³, E. Montagud-Marrahi¹, F. Cofan¹, J. Torregrosa¹, M. Bodro⁴, A. Moreno⁴, P. Ventura-Aguiar¹, D. Cucchiari¹, N. Esforzado¹, G. Piñeiro¹, J. Ugalde-Altamirano¹, J. Campistol¹, A. Alcaraz⁵, B. Bayès¹, E. Poch¹, F. Oppenheimer¹, F. Diekmann¹
¹Department of Nephrology and Kidney Transplant, Hospital Clinic, Barcelona, Spain, ²Faculty of Economics and Management, Free University of Bolzano, Bolzano, Italy, ³Department of Economics and Management, University of Trento, Trento, Italy, ⁴Department of Infectious Diseases, Hospital Clinic, Barcelona, Spain, ⁵Department of Urology, Hospital Clinic, Barcelona, Spain
*Purpose: Health systems need tools to deal with COVID-19, especially for high-risk population,such as transplant recipients. Predictive models are necessary to improve management of patients…
2021 American Transplant Congress
Challenges and Stressors of COVID-19 Kidney and Transplant Patients: A Mixed Methods Study
Y. A. Iraheta¹, A. L. Murillo², E. H. Wood¹, S. M. Advani³, R. Pines⁴, A. D. Waterman¹
¹UCLA David Geffen School of Medicine, Los Angeles, CA, ²Terasaki Institute, Los Angeles, CA, ³National Human Genome Research Institute (NIH), Bethesda, MD, ⁴Santa Barbara Cottage Hospital, Santa Barbara, CA
*Purpose: To assess the unique needs of at-risk kidney and transplant patients and their caregivers during COVID-19, we established a telephone Listening Center enabling them…
2021 American Transplant Congress
Successful Long-Term TMA- and Rejection-Free Survival of a Kidney Xenograft With Triple Xenoantigen Knockout Plus Insertion of Multiple Human Transgenes
T. Hirose¹, D. Ma¹, G. Lassiter¹, H. Sasaki¹, I. Rosales², T. Coe¹, C. Rickert¹, R. Matheson¹, R. Colvin², W. Qin³, Y. Kan³, J. Layer³, K. Stiede³, K. Hall³, M. Youd³, W. Westlin³, M. Curtis³, J. F. Markmann¹, T. Kawai¹
¹Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, ²Pathology, Massachusetts General Hospital, Boston, MA, ³eGenesis Inc, Cambridge, MA
*Purpose: Pigs with deletion of 3 carbohydrate xenoantigens (triple knock-out, TKO) are expected to be optimal donors for human xenotransplantation. However, anti-porcine natural antibodies of…
2021 American Transplant Congress
Transplanting Hepatitis C Infected Organs Into Uninfected Recipients: A Pharmacy Perspective
M. L. Holt, A. James, K. Gutierrez, T. Sparkman, J. Banbury, D. Jones
University of Alabama at Birmingham Hospital, Birmingham, AL
*Purpose: Due to direct acting antivirals (DAAs), hepatitis C virus (HCV) positive patients are now resources for organ transplantation in HCV negative recipients. Our institution…
2021 American Transplant Congress
Does the NSQIP-Transplant Experience Demonstrate That Obese Kidney Transplant Recipients are Still at Increased Risk for Surgical Site Infections?
H. C. Yaffe¹, A. K. Belli¹, J. R. Parekh², D. L. Sudan³, N. Elias⁴, K. D. Conzen⁵, D. P. Foley⁶, R. Hirose⁷, S. M. Greenstein¹
¹Surgery, Montefiore-Einstein Center for Transplantation, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, ²Surgery, University of California San Diego, San Diego, CA, ³Surgery, Division of Abdominal Transplant Surgery, Duke University Medical Center, Durham, NC, ⁴Surgery, Transplant Surgery Division, Massachusetts General Hospital, Boston, MA, ⁵Surgery, Division of Transplant Surgery, University of Colorado Hospital, Aurora, CO, ⁶Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, ⁷Surgery, University of California San Francisco, San Francisco, CA
*Purpose: The National Surgical Quality Improvement Program for Transplant (NSQIP-T) was designed to track surgical outcomes in adult liver and kidney transplants (KTX). The Pilot…
2021 American Transplant Congress
Predicted Heart Mass Difference as a Risk Factor for Severe Primary Graft Dysfunction in the Contemporary Era of Heart Transplantation: A Report from the International Consortium on Primary Graft Dysfunction
F. Foroutan¹, L. K. Truby², Y. Moayedi¹, J. Han³, J. Guzman⁴, M. Farrero⁴, E. Baughan⁵, M. Farr⁵, H. Zafar⁶, J. Felius⁶, J. van Zyl⁷, D. Law⁸, S. Chih⁸, P. Angleitner⁹, M. Sabatino¹⁰, A. DeVore², R. J. Miller¹¹, L. Potena¹⁰, A. Zuckermann⁹, K. K. Khush³, S. A. Hall⁶, H. J. Ross¹
¹Ted Rogers Centre for Heart Research, Toronto, ON, Canada, ²Duke University School of Medicine, Durham, NC, ³Stanford University, Stanford, CA, ⁴Clinic Barcelona Hospital Universitari, Barcelona, Spain, ⁵Columbia University Medical Center, New York, NY, ⁶Baylor University Medical Center, Dallas, TX, ⁷Dallas University Medical Center, Dallas, TX, ⁸University of Ottawa Heart Institute, Ottawa, ON, Canada, ⁹Medical University of Vienna, Vienna, Austria, ¹⁰Bologna University Hospital, Bologna, Italy, ¹¹University of Calgary, Calgary, AB, Canada
*Purpose: Primary Graft Dysfunction (PGD) increases early mortality after heart transplant (HT). Predicted heart mass (PHM) difference may be a risk factor for PGD. Lack…
2021 American Transplant Congress
The Intersection of Cost, Quality, and Volume in Liver Transplant
D. Axelrod¹, R. Balakrishnan¹, A. Harris², S. Hohmann², J. Snyder³, B. Kasiske³, M. Schnitzler⁴, K. Lentine⁴
¹Univ of Iowa, Iowa City, IA, ²Vizient Inc., Irving, TX, ³SRTR, Minneapolis, MN, ⁴Saint Louis Univ, Saint Louis, MO
*Purpose: As a consequence of changing allocation practices and the ongoing shortage of high-quality organs, the cost of liver transplant (LT) continues to increase throughout…
2021 American Transplant Congress
Aligning Pediatric Waiting List and Post-Transplant Outcomes with the Adult Lung Allocation Score
M. Skeans¹, A. Wey¹, E. Lease², C. Lehr³, J. Alcorn⁴, R. Goff⁴, D. Stewart⁴, M. Valapour³
¹SRTR, Minneapolis, MN, ²Univ of Washington, Seattle, WA, ³Cleveland Clinic, Cleveland, OH, ⁴UNOS, Richmond, VA
*Purpose: Lung allocation is moving toward a continuous distribution framework (CDF), with components for waitlist (WL) urgency and post-transplant (PT) survival, as computed in LAS.…
2021 American Transplant Congress
The Microenvironment of Belatacept-Resistant Rejection
A. Johnson, J. Zhang, C. Larsen
Surgery, Emory University, Atlanta, GA
*Purpose: Belatacept is a co-stimulation blockade immunosuppressant, that despite demonstrating improved long-term outcomes, has not been widely adopted, in part, due to concern over early…
2021 American Transplant Congress
Quantifying Hidden Sensitization: HLA-reactive Memory B Cells in the Spleens of Sensitized Women
J. T. Killian¹, J. A. Houp¹, A. Nellore², R. G. King³, P. M. Porrett¹, F. E. Lund³
¹Department of Surgery, University of Alabama at Birmingham School of Medicine, Birmingham, AL, ²Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, AL, ³Department of Microbiology, University of Alabama at Birmingham School of Medicine, Birmingham, AL
*Purpose: Measurement of circulating anti-HLA antibody (anti-HLA-Ab) in transplant candidates and recipients is required for successful organ transplantation. However, serum Ab measurement alone likely underestimates…